The anti-Aspergillus drug pipeline: Is the glass half full or empty?

Osherov, N; Kontoyiannis, DP

Kontoyiannis, DP (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Infect Control & Employee Hlth, Houston, TX 77030 USA.

MEDICAL MYCOLOGY, 2017; 55 (1): 118

Abstract

Aspergillosis has emerged as important human mycoses, in view of the ever expanding population at risk. The emergence of resistance to the most common......

Full Text Link